Take a look into the genetic code of the flu virus as researchers get closer to preventing the illness from countless ...

BioArctic's PyroGlu-Aβ antibody program consists of novel antibodies targeting a specific truncated, pyroglutamate modified form of amyloid-beta. Monomers of PyroGlu-Aβ are highly prone to aggregate, ...

However, we showed recently that a homozygous nonsense mutation in NEFL led to a complete absence of NFL instead of a truncated protein in patient-specific stem cell–derived neurons (Sainio et al., ...

BioArctic (BRCTF) announced that it has entered into a global exclusive license agreement with Bristol Myers Squibb (BMY) for BioArctic’s ...

In this manuscript, Yao et al. present solid evidence to show that MnMYL3 may serve as a receptor for NNV via macropinocytosis. This manuscript is valuable for understanding the molecular mechanisms ...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...

Fintel reports that on December 16, 2024, HC Wainwright & Co. downgraded their outlook for Carisma Therapeutics ...

Tyra Biosciences' shares have dropped sharply after interim data from TYRA-300 showed a superior but not exceptional adverse ...

Both agents attack amyloid protein, and both slow the advancement of dementia by several months ... ¹ Donanemab is a ...

Genetic polymorphisms have been described in the case of several CYP isoenzymes. The best explored example of this phenomenon is the CYP2C19 polymorphism. In this table the most frequent alleles ...

We came across a bullish thesis on Sarepta Therapeutics, Inc. (SRPT) on Substack by Two Natural Capital. In this article, we ...